195 related articles for article (PubMed ID: 8617406)
1. Opioid and anti-opioid peptides.
Cesselin F
Fundam Clin Pharmacol; 1995; 9(5):409-33. PubMed ID: 8617406
[TBL] [Abstract][Full Text] [Related]
2. Opioid-modulating peptides: mechanisms of action.
Mollereau C; Roumy M; Zajac JM
Curr Top Med Chem; 2005; 5(3):341-55. PubMed ID: 15857316
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between Opioid and Anti-Opioid Systems: An Overview and Its Possible Therapeutic Significance.
Gibula-Tarlowska E; Kotlinska JH
Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32998249
[TBL] [Abstract][Full Text] [Related]
4. [Interactions between central opioidergic and cholecystokininergic systems in rats: possible significance for the development of of opioid tolerance].
Benoliel JJ; Becker C; Mauborgne A; Bourgoin S; Hamon M; Cesselin F
Bull Acad Natl Med; 1998; 182(2):311-24. PubMed ID: 9648346
[TBL] [Abstract][Full Text] [Related]
5. Opioids in chronic pain.
Przewłocki R; Przewłocka B
Eur J Pharmacol; 2001 Oct; 429(1-3):79-91. PubMed ID: 11698029
[TBL] [Abstract][Full Text] [Related]
6. Non-Opioid Peptides Targeting Opioid Effects.
Kaczyńska K; Wojciechowski P
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948415
[TBL] [Abstract][Full Text] [Related]
7. The role of CCK2 receptors in the homeostasis of the opioid system.
Noble F; Roques BP
Drugs Today (Barc); 2003 Nov; 39(11):897-908. PubMed ID: 14702135
[TBL] [Abstract][Full Text] [Related]
8. Endogenous opiates and behavior: 2012.
Bodnar RJ
Peptides; 2013 Dec; 50():55-95. PubMed ID: 24126281
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effects of opioids.
Walker JS
Adv Exp Med Biol; 2003; 521():148-60. PubMed ID: 12617572
[TBL] [Abstract][Full Text] [Related]
10. Role of cholecystokinin and opioid peptides in control of food intake.
Baile CA; McLaughlin CL; Della-Fera MA
Physiol Rev; 1986 Jan; 66(1):172-234. PubMed ID: 2868468
[TBL] [Abstract][Full Text] [Related]
11. Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system.
Pommier B; Beslot F; Simon A; Pophillat M; Matsui T; Dauge V; Roques BP; Noble F
J Neurosci; 2002 Mar; 22(5):2005-11. PubMed ID: 11880531
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin octapeptide induces endogenous opioid-dependent anxiolytic effects in morphine-withdrawal rats.
Wen D; Sun D; Zang G; Hao L; Liu X; Yu F; Ma C; Cong B
Neuroscience; 2014 Sep; 277():14-25. PubMed ID: 24993476
[TBL] [Abstract][Full Text] [Related]
13. Spinal opioid systems in inflammation.
Stanfa L; Dickenson A
Inflamm Res; 1995 Jun; 44(6):231-41. PubMed ID: 7583517
[TBL] [Abstract][Full Text] [Related]
14. Endogenous opiates and behavior: 2014.
Bodnar RJ
Peptides; 2016 Jan; 75():18-70. PubMed ID: 26551874
[TBL] [Abstract][Full Text] [Related]
15. Opioid-modulating properties of the neuropeptide FF system.
Moulédous L; Mollereau C; Zajac JM
Biofactors; 2010; 36(6):423-9. PubMed ID: 20803521
[TBL] [Abstract][Full Text] [Related]
16. Specific N- or C-terminus modified dynorphin and beta-endorphin peptides can selectively block excitatory opioid receptor functions in sensory neurons and unmask potent inhibitory effects of opioid agonists.
Shen KF; Crain SM
Brain Res; 1995 Feb; 673(1):30-8. PubMed ID: 7757476
[TBL] [Abstract][Full Text] [Related]
17. Involvement of different subtypes of cholecystokinin receptors in opioid antinociception in the mouse.
Suh HW; Kim YH; Choi YS; Song DK
Peptides; 1995; 16(7):1229-34. PubMed ID: 8545243
[TBL] [Abstract][Full Text] [Related]
18. Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction.
Roques BP; Noble F
Neurochem Res; 1996 Nov; 21(11):1397-410. PubMed ID: 8947930
[TBL] [Abstract][Full Text] [Related]
19. [Modulation of calcium conductance by opioid and anti-opioid peptides].
Roumy M; Zajac JM
J Soc Biol; 2001; 195(3):277-83. PubMed ID: 11833465
[TBL] [Abstract][Full Text] [Related]
20. Multiple opioid receptor systems in brain and spinal cord: Part I.
Yaksh TL
Eur J Anaesthesiol; 1984 Jun; 1(2):171-99. PubMed ID: 6152613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
